RxDoctor Payments Data

Alaaeldin Shalaby

Clinical Cardiac Electrophysiology · Pittsburgh, PANPI 1316912595

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (43.4%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Abbott at 40.3% of the total. 2025 is the largest year on record at $16,575, 9.8 times the $1,696 reported in 2019.

$34,080in general payments, 2019–2025

Across 173 payments — averaging $196.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$14K
  • Medtronic$12K
  • Boston Scientific$4K
  • Atricure, Inc.$2K
  • Biotronik Inc.$1K
  • Cardiofocus, Inc.$849
  • plus $376 from 6 others
$153,715in research payments, 2019–2025

Across 39 payments — averaging $3941.41 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • American Regent$154K

What the payments were for

  • Consulting fees$8,91326%
  • Speaking & faculty fees$3,75011%
  • Grants$1470%
  • Travel & lodging$14,79243%
  • Food & beverage$6,47819%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$34,080 in reported general payments places this provider in the 70th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.

See all clinical cardiac electrophysiology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$61,207
Medicare patients
221
Services billed
471

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban56$56,777
XareltoRivaroxaban11$13,070
Dofetilide13$2,478
Bisoprolol Fumarate15$711
Amiodarone Hcl44$670
Metoprolol Succinate49$544
Metoprolol Tartrate16$150
SotalolSotalol Hcl11$106

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →